Urology最新文献

{"title":"Reply to Letter to the Editor on “The Change of Detrusor Contractility at 5 Years After Transurethral Resection of the Prostate: A Single-center Prospective Observational Study”","authors":"Naoya Masumori","doi":"10.1016/j.urology.2025.03.037","DOIUrl":"10.1016/j.urology.2025.03.037","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 249-250"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143693517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Editorial Comment on “The Impact of American Board of Urology Certification on Postoperative Outcomes for Patients: Assessing National Trends”","authors":"Christopher J. Kane","doi":"10.1016/j.urology.2025.03.046","DOIUrl":"10.1016/j.urology.2025.03.046","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Page 237"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to Editorial Comment on “Correlation of 17-OH Progesterone Changes With Semen Parameters and Pregnancy Outcomes in Hypogonadal and Eugonadal Patients After Varicocelectomy”","authors":"Muhammed Arif Ibis , Murat Can Karaburun , Cagri Akpinar , Onder Yaman","doi":"10.1016/j.urology.2025.04.031","DOIUrl":"10.1016/j.urology.2025.04.031","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 89-90"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pan Abdominal Wall Emphysema in Emphysematous Pyelonephritis: Wait or Operate?","authors":"Jay Mehta, Sudheer K. Devana, Aditya Prakash Sharma","doi":"10.1016/j.urology.2025.04.015","DOIUrl":"10.1016/j.urology.2025.04.015","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages e61-e62"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of Abortion Laws on the Decision to Undergo Vasectomy","authors":"Parviz K. Kavoussi ,&nbsp;Romtin Mehrabani-Farsi ,&nbsp;Hayden T. Henderson ,&nbsp;Arya Farahi ,&nbsp;Negar Farzaneh ,&nbsp;Shahryar K. Kavoussi","doi":"10.1016/j.urology.2025.02.035","DOIUrl":"10.1016/j.urology.2025.02.035","url":null,"abstract":"<div><h3>Rationale and Objectives</h3><div>To assess trends in men who underwent vasectomy before and after the Texas abortion law which passed on May 19, 2021, and the direct impact of the reversal of Roe v. Wade on June 24, 2022, on the decision for vasectomy.</div></div><div><h3>Materials and Methods</h3><div>Retrospective review of the electronic health records from a private reproductive urology center, including all consecutive patients undergoing vasectomy with no exclusions from October 1, 2010 to June 26, 2022.</div></div><div><h3>Results</h3><div>Data were reviewed on 2642 men who underwent vasectomy. After the Texas law change men were younger and had fewer children, there was a higher percentage without children, than those who underwent vasectomy prior. There were more single men who underwent vasectomy after.</div><div>Of 377 men who underwent vasectomy following the overturning of Roe v. Wade, 39.3% reported it directly impact their decision for vasectomy. The men who reported it impacted their decision had fewer number of children at the time of vasectomy. There was not a difference in marital status impacting the Supreme Court of the United States (SCOTUS) rulings effect on the decision for vasectomy.</div></div><div><h3>Conclusion</h3><div>There is an association between the Texas abortion law and trends in younger men seeking vasectomy with fewer children, more men without children, and more single men opting for vasectomy following the law. Of men who underwent vasectomy following the SCOTUS ruling overturning Roe v. Wade, 39.3% reported the ruling directly impacted their decision for vasectomy. These men had fewer children at the time of vasectomy and no difference in marital status compared to men who the ruling did not impact their decision for vasectomy.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 72-76"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143537765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER)","authors":"Raees Cassim ,&nbsp;Rahul Bansal ,&nbsp;Braden Millan ,&nbsp;Oleg Mironov ,&nbsp;Priya Ahir ,&nbsp;Camilla Tajzler ,&nbsp;Jen Hoogenes ,&nbsp;Edward D. Matsumoto ,&nbsp;Kimmen Quan ,&nbsp;Anil Kapoor ,&nbsp;Anand Swaminath","doi":"10.1016/j.urology.2025.02.053","DOIUrl":"10.1016/j.urology.2025.02.053","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the feasibility of a trial comparing stereotactic beam radiation therapy (SBRT) and radiofrequency ablation (RFA) for small renal masses (SRM).</div></div><div><h3>Methods</h3><div>Patients opting for treatment of a SRM at a single center were randomized 1:1 to SBRT or RFA. Crossover if ineligible for treatment after randomization was allowed. Biopsies were completed prior to randomization and 12 months post-treatment. Our primary outcome was feasibility of the trial design. Secondary outcomes included treatment efficacy and safety.</div></div><div><h3>Results</h3><div>Over 18 months, 33 patients were screened resulting in the recruitment and randomization of 24 patients (SBRT = 12; RFA = 12). Fourteen received SBRT, 7 RFA, and 3 dropped out. Crossover occurred from RFA to SBRT due to inability to perform RFA. Mean estimated glomerular filtration rate (EGFR) reduction was similar at 1 year (RFA −3 ml/minutes/1.73 m², SBRT −5.3 ml/minutes/1.73 m², <em>P</em> = .7). One-year biopsies were performed in 95.2% (20/21) of patients receiving treatment. Per protocol analysis demonstrated a higher pathologic response (RFA 100% vs SBRT 33.3.%, <em>P</em> = .01) in patients undergoing RFA compared to SBRT but not in the intention to treat analysis. No patients developed local failure, metastasis or death during the study period.</div></div><div><h3>Conclusion</h3><div>Recruitment, randomization, and follow-up of patients with SRMs was feasible and our results support performing a larger randomized trial. Multidisciplinary evaluation of patients before randomization is needed to assess RFA feasibility to reduce crossover. Both treatments have excellent short-term safety profiles. While not a surrogate for clinical response, RFA had a non-statistically significant improvement in pathological response.</div><div>Clinicaltrials.gov: NCT03811665</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 118-124"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143586743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder Cancer","authors":"Mattia Longoni ,&nbsp;Natali Rodriguez Peñaranda ,&nbsp;Andrea Marmiroli ,&nbsp;Fabian Falkenbach ,&nbsp;Quynh Chi Le ,&nbsp;Michele Nicolazzini ,&nbsp;Calogero Catanzaro ,&nbsp;Zhe Tian ,&nbsp;Jordan A. Goyal ,&nbsp;Stefano Puliatti ,&nbsp;Ottavio De Cobelli ,&nbsp;Markus Graefen ,&nbsp;Felix K.H. Chun ,&nbsp;Carlotta Palumbo ,&nbsp;Riccardo Schiavina ,&nbsp;Fred Saad ,&nbsp;Shahrokh F. Shariat ,&nbsp;Marco Moschini ,&nbsp;Giorgio Gandaglia ,&nbsp;Francesco Montorsi ,&nbsp;Pierre I. Karakiewicz","doi":"10.1016/j.urology.2025.02.051","DOIUrl":"10.1016/j.urology.2025.02.051","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate whether bimodal therapy (BMT) or trimodal therapy (TMT) differ from radical cystectomy (RC) + perioperative chemotherapy (CT) in cancer control outcomes among patients with non-organ-confined (NOC; T3-4 and/or N1-3) urothelial carcinoma of the urinary bladder (UCUB).</div></div><div><h3>Methods</h3><div>Within the Surveillance, Epidemiology, and End Results database (2005-2021), rates of BMT vs TMT vs RC + CT use in NOC UCUB patients were tabulated. Nearest-neighbor 1:1 propensity score matching (PSM) for age, sex, stage, and race/ethnicity was applied. Cumulative incidence plots depicted 5-year cancer-specific (CSM) and other-cause mortality (OCM) rates. Univariable and multivariable competing risks regression (CRR) models were fitted. Sensitivity analyses focused within T3-4,N0 patients.</div></div><div><h3>Results</h3><div>Of 7401 NOC UCUB patients, 1645 (22.2%) received BMT vs 884 (11.9%) TMT vs 4872 (65.8%) RC+CT. Over the study period, BMT and TMT rates have not significantly changed. After PSM, the five-year CSM rate was 66.2% after BMT vs 44.9% after RC + CT and BMT was associated with 2.1-fold higher CSM relative to RC + CT (multivariable HR [mHR]: 2.12, <em>P</em> &lt;.001). After PSM, 5-year CSM rates was 61.1% after TMT vs 46.6% after RC and TMT was associated with 1.6-fold higher CSM relative to RC (mHR: 1.63, <em>P</em> &lt;.001). Virtually the same findings were found within T3-4,N0 patients.</div></div><div><h3>Conclusion</h3><div>Approximately three out of ten NOC UCUB patients were treated with either BMT or TMT. However, such practice was invariably associated with higher CSM relative to RC + CT. These observations should be discussed at clinical decision-making and prior to informed consent.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 107-113"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143586919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to Editorial Comment on “Comparative Efficacy of Dorsal-Onlay and Ventral-Inlay Buccal Mucosal Graft Urethroplasty in Female Urethral Stricture: A Randomized Clinical Trial”","authors":"Swarnendu Mandal,&nbsp;Prasant Nayak","doi":"10.1016/j.urology.2025.03.020","DOIUrl":"10.1016/j.urology.2025.03.020","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Page 61"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143670849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pelvic Mass in a Pediatric Patient: A Rare Case of Extraosseous Ewing Sarcoma","authors":"Deepansh Dalela ,&nbsp;Sarah Attia ,&nbsp;Dinesh Rakheja ,&nbsp;Shane Batie ,&nbsp;Alexandra Carolan ,&nbsp;Irina Stanasel","doi":"10.1016/j.urology.2025.03.038","DOIUrl":"10.1016/j.urology.2025.03.038","url":null,"abstract":"<div><div>Ewing sarcoma (ES) is a common malignant bone tumor in children, but primary extraosseous Ewing sarcoma (EES) in the pelvic region is particularly rare. We report a 21-month-old male with a 10-cm complex cystic mass adherent to the bladder. Core biopsy demonstrated a small round cell neoplasm positive for CD99, NKX2-2, and EWSR1:ERG fusion. The patient had a residual mass following induction chemotherapy, and underwent surgical resection with anterior detrusorrhaphy with no other pelvic organ involvement. Pathology showed &lt;10% residual tumor with negative margins. Following completion of consolidation chemotherapy, imaging has shown no evidence of recurrent disease 13 months post-surgery.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages e76-e79"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incontinent Enterovesicostomy in the Pediatric Population: A Feasible Option for Surgical Management of Neurogenic Bladder","authors":"Benjamin Press ,&nbsp;Elizabeth Chu ,&nbsp;Nahal Orak ,&nbsp;Corey Weinstein ,&nbsp;Edwin Smith ,&nbsp;Andrew Kirsch ,&nbsp;Shuvro De ,&nbsp;Michael Garcia-Roig","doi":"10.1016/j.urology.2025.04.021","DOIUrl":"10.1016/j.urology.2025.04.021","url":null,"abstract":"<div><h3>Objective</h3><div>To report outcomes of a series of pediatric patients undergoing incontinent enterovesicostomy. Incontinent enterovesicostomy is a viable procedure for bladder reconstruction in pediatric patients with neurogenic bladder, but clinical outcomes data in this age group are scarce.</div></div><div><h3>Materials and Methods</h3><div>A retrospective chart review was conducted on pediatric patients (&lt;18 years old) who underwent incontinent enterovesicostomy at a single institution between 2011 and 2024. Data were collected from electronic medical records and analyzed using descriptive statistics.</div></div><div><h3>Results</h3><div>A total of 26 pediatric patients (14 female, 12 male) with neurogenic bladder underwent incontinent enterovesicostomy at a median age of 12.4<!--> <!-->years (IQR: 6.4-14.0<!--> <!-->years). The median follow-up duration was 18.99<!--> <!-->months (IQR: 11.2-44.7<!--> <!-->months), and most patients (76.9%) had a primary diagnosis of myelomeningocele. Indications for surgery included recurrent urinary infections, urethral incontinence, and bladder hostility. The median operative time was 241.5 minutes (IQR: 192-273 minutes), and the median hospital stay was 5<!--> <!-->days. Within 30<!--> <!-->days postsurgery, 76.9% of patients experienced no complications. Renal function remained stable in all patients, and hydronephrosis status worsened in only 1 patient.</div></div><div><h3>Conclusion</h3><div>Enterovesicostomy is a safe, feasible, and effective surgical option for managing neurogenic bladder in pediatric patients. It reliably treats bladder hostility and protects upper urinary tract function with a low complication rate. Future research should focus on prospective, multicenter studies comparing long-term outcomes of incontinent enterovesicostomy with augmentation cystoplasty.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"200 ","pages":"Pages 186-190"},"PeriodicalIF":2.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144029966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}